ITEOS THERAPEUTICS INC (ITOS)

US46565G1040 - Common Stock

10.8  +0.2 (+1.89%)

After market: 10.8 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
12.60M267.60M344.80M0.000.00
Operating Expenses
163.70M141.30M99.90M45.20M28.00M
Research and Development
113.30M97.40M59.40M29.90M19.20M
Selling, General, and Administrative Expenses
50.40M43.90M40.50M15.30M8.80M
Operating Income
-151.10M126.30M244.90M-45.20M-28.00M
Interest Income/Expense
31.77M11.40MN/AN/A0.00
Other Income/Expense
10.30M11.10M11.60M7.20M5.70M
Income Before Taxes
-109.03M148.70M256.50M-38.10M-22.30M
Income Tax
3.61M52.10M41.90M-100.00K100.00K
Net Income
-112.64M96.70M214.50M-43.40M-26.50M
EBITDA
-150.20M127.10M245.50M-44.70M-27.40M
 
Per Share Data
EPS Diluted Total Ops
-3.152.565.68-1.24-0.80
Non GAAP EPS
-3.15N/A5.61N/AN/A
 
Statistics
Profit Margin
-894.34%36.14%62.21%N/AN/A
Operating Profit Margin
-1199.69%47.20%71.03%N/AN/A

All data in USD

Charts